September 17, 2025

Vanderbilt team launches AI-powered project to improve obesity care

The study will analyze electronic health records, survey patients and clinicians, and use artificial intelligence to identify why many patients discontinue obesity treatment.

By Paul Govern

October 17, 2023

Tirzepatide trial shows additional 21.1% weight loss following intensive lifestyle intervention

A Vanderbilt clinical trial evaluating the injectable prescription medication tirzepatide, showed an additional 21.1% weight loss after intensive lifestyle intervention in adults with obesity or who were overweight with weight-related comorbidities, excluding Type 2 diabetes.

By Jill Clendening